GLENN LYONS: Open Payments
NPI 1265629547 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 50 payments from 15 companies in 2025. Trend: 2023 $992 · 2024 $1,472 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $321 |
| AstraZeneca Pharmaceuticals LP | 10 | $204 |
| Lilly USA, LLC | 5 | $117 |
| Astellas Pharma US Inc | 3 | $85 |
| Novo Nordisk Inc | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Boston Scientific Corporation | 2 | $46 |
| Exact Sciences Corporation | 2 | $45 |
| PFIZER INC. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $41 |
Products named: QULIPTA, MOUNJARO, UBRELVY, BREZTRI, FARXIGA, Veozah, VRAYLAR, CAPLYTA.
Industry payments across NY — which companies pay providers there.
